SCHEMBL17633451

SCHEMBL17633451

Cc1c2ccnc(N)c2c(C)c2c1[nH]c1ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
MAPT P10636 4/20 0.58
KMT2A Q03164 4/20 0.58
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 2/20 0.58
HPGD P15428 2/20 0.58
TSHR P16473 2/20 0.58
NFKB1 P19838 2/20 0.58
APEX1 P27695 2/20 0.58
MAPK1 P28482 2/20 0.58
BLM P54132 2/20 0.58
NPSR1 Q6W5P4 2/20 0.58
HSD17B10 Q99714 2/20 0.58
NPC1 O15118 2/20 0.58
POLB P06746 2/20 0.58
GAA P10253 2/20 0.58
RAB9A P51151 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082102 0.85 GABRA1 (0.62) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL15413439 0.80 MEN1 (0.55) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL32690150 0.80 MEN1 (0.55) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL2311502 0.79 KDM4E (0.63) MEN1MAPTKMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL15413335 0.79 MEN1 (0.54) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL30448074 0.78 UTS2R (0.54) ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL10546827 0.78 UTS2R (0.54) ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL4342832 0.78 KDM4E (0.53) MEN1MAPTKMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30448693 0.77 UTS2R (0.53) ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL17633446 0.77 MEN1 (0.51) MEN1MAPTKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197501-B1 BIOLOGICAL MATERIALS AND USES THEREOF ANTIKOR BIOPHARMA LTD (GB) 2024-04-10 EP disclosed
US-11202837-B2 Biological materials and uses thereof ANTIKOR BIOPHARMA LIMITED (GB) 2021-12-21 US disclosed
US-20170360951-A1 BIOLOGICAL MATERIALS AND USES THEREOF ANTIKOR BIOPHARMA LIMITED (GB) 2017-12-21 US disclosed
EP-3197501-A1 BIOLOGICAL MATERIALS AND USES THEREOF Antikor Biopharma Limited (GB) 2017-08-02 EP disclosed
CN-106999605-A Biological material and use thereof 安迪高生物制药有限公司 2017-08-01 CN disclosed
WO-2016046574-A1 BIOLOGICAL MATERIALS AND USES THEREOF ANTIKOR BIOPHARMA LIMITED (GB) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11202837-B2 Biological materials and uses thereof CD47, LNPEP, TIE1 MEN1 275/4885MAPT 862/4885KMT2A 1039/4885
US-20170360951-A1 BIOLOGICAL MATERIALS AND USES THEREOF CD47, LNPEP, TIE1 MEN1 275/4885MAPT 862/4885KMT2A 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.